Clinical Pharmacokinetics

Buprenorphine: Clinical Pharmacokinetics in the Treatment of Opioid Dependence
pp. 661-680(20)
Authors: Elkader, Alexander; Sproule, Beth

Pharmacokinetics of Hydroxyethyl Starch
pp. 681-699(19)
Authors: Jungheinrich, Cornelius; Neff, Thomas A.

Clinical Pharmacokinetics of Trospium Chloride
pp. 701-720(20)
Authors: Doroshyenko, Oxana; Jetter, Alexander; Odenthal, Karl P.; Fuhr, Uwe

Steady-State Pharmacokinetics of a Novel Extended-Release Metformin Formulation
pp. 721-729(9)
Authors: Timmins, Peter; Donahue, Steve; Meeker, Jeff; Marathe, Punit

Paradoxical Role of Cytochrome P450 3A in the Bioactivation and Clinical Effects of Levo--Acetylmethadol: Importance of Clinical Investigations to Validate In Vitro Drug Metabolism Studies
pp. 731-751(21)
Authors: Kharasch, Evan D.; Whittington, Dale; Hoffer, Christine; Krudys, Kevin; Craig, Keith; Vicini, Paolo; Sheffels, Pam; Lalovic, Bojan

Modafinil Influences the Pharmacokinetics of Intravenous Cocaine in Healthy Cocaine-Dependent Volunteers
pp. 753-765(13)
Authors: Donovan, Jennifer L.; DeVane, C. Lindsay; Malcolm, Robert J.; Mojsiak, Jurij; Chiang, C. Nora; Elkashef, Ahmed; Taylor, Robin M.

Relationship Between Minimum Inhibitory Concentration and Stationary Concentration Revisited: Growth Rates and Minimum Bactericidal Concentrations
pp. 767-768(2)
Author: Adis International Limited,